HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial.

AbstractBACKGROUND:
Tricyclic antidepressants (TCA) provide less than satisfactory pain relief for postherpetic neuralgia (PHN), and the role of opioids is controversial.
OBJECTIVE:
To compare the analgesic and cognitive effects of opioids with those of TCA and placebo in the treatment of PHN.
METHODS:
Seventy-six patients with PHN were randomized in a double-blind, placebo-controlled, crossover trial. Each subject was scheduled to undergo three treatment periods (opioid, TCA, and placebo), approximately 8 weeks' duration each. Doses were titrated to maximal relief or intolerable side effects. The primary outcome measures were pain intensity (0 to 10 scale), pain relief (0 to 100%), and cognitive function. Analyses included patients who provided any pain ratings after having received at least a single dose of a study medication.
RESULTS:
Fifty patients completed two periods, and 44 patients completed all three. Mean daily maintenance doses were morphine 91 mg or methadone 15 mg and nortriptyline 89 mg or desipramine 63 mg. Opioids and TCA reduced pain (1.9 and 1.4) more than placebo (0.2; p < 0.001), with no appreciable effect on any cognitive measure. The trend favoring opioids over TCA fell short of significance (p = 0.06), and reduction in pain with opioids did not correlate with that following TCA. Treatment with opioids and TCA resulted in greater pain relief (38 and 32%) compared with placebo (11%; p < 0.001). More patients completing all three treatments preferred opioids (54%) than TCA (30%; p = 0.02).
CONCLUSIONS:
Opioids effectively treat PHN without impairing cognition. Opioids and TCA act via independent mechanisms and with varied individual effect.
AuthorsS N Raja, J A Haythornthwaite, M Pappagallo, M R Clark, T G Travison, S Sabeen, R M Royall, M B Max
JournalNeurology (Neurology) Vol. 59 Issue 7 Pg. 1015-21 (Oct 8 2002) ISSN: 0028-3878 [Print] United States
PMID12370455 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Analgesics, Opioid
  • Antidepressive Agents
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Analgesics, Opioid (adverse effects, pharmacology, therapeutic use)
  • Antidepressive Agents (adverse effects, pharmacology, therapeutic use)
  • Confidence Intervals
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Herpes Zoster (complications, drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Neuralgia (drug therapy, etiology)
  • Pain Measurement (drug effects, statistics & numerical data)
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: